Evidence map›Paper›PMID 39673672›Full record

ArticleCEN case reports2025

Diffuse large B-cell lymphoma with rapid kidney enlargement after induction of hemodialysis in a patient with IgG4-related disease.

Shintaro Hara, Daisuke Morita, Ryoko Shibata, Yuki Yasui, Yoshiki Naito, Noriyoshi Fukushima, Seiya Kato, Noriko Uesugi, Yasuhiro Abe, Kosuke Masutani

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shintaro HaraDivision of Nephrology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Daisuke MoritaDivision of Nephrology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Ryoko ShibataDivision of Nephrology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Yuki YasuiDivision of Nephrology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Yoshiki NaitoDepartment of Pathology, Kurume University, Kurume, Japan.
Noriyoshi FukushimaDepartment of Pathology, Jichi Medical University, Tochigi, Japan.
Seiya KatoDepartment of Pathology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Noriko UesugiDepartment of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yasuhiro AbeDivision of Nephrology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
Kosuke MasutaniDivision of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan. kmasutani@fukuoka-u.ac.jp.ORCID 0000-0001-9190-4600

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 76-year-old Japanese man was incidentally diagnosed with a pancreatic head tumor on computed tomography after surgery for colon cancer. He underwent pancreatoduodenectomy and was diagnosed with IgG4-related autoimmune pancreatitis. Concurrent chronic kidney disease gradually progressed and chronic hemodialysis was introduced 2 years later. Six months after the introduction of hemodialysis, follow-up abdominal computed tomography revealed marked enlargement of bilateral kidneys compared with previous images. Blood tests revealed persistent high IgG and IgG4 levels, and IgG4-related kidney disease was suspected. Thus, percutaneous kidney biopsy was performed. No evidence of IgG4-related kidney disease was detected, and a diagnosis of diffuse large B-cell lymphoma was made. Six courses of combination chemotherapy consisting of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone was effective, and the patient achieved and maintained complete remission for five years. This case highlights the need to consider the possible development of malignant lymphoma within several years after IgG4-related disease, especially in cases of autoimmune pancreatitis.

Indexed as

Autoimmune PancreatitisImmunoglobulin G4-Related DiseaseLymphoma, Large B-Cell, DiffuseRenal DialysisAgedAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinHumansImmunoglobulin GKidneyMalePrednisoneRenal Insufficiency, ChronicRituximabTomography, X-Ray ComputedCyclophosphamideDoxorubicinImmunoglobulin GPrednisoneRituximabVincristineAutoimmune pancreatitisChronic inflammationCytokineKidney biopsyStoriform fibrosis

Identifiers

PMID39673672
PMCPMC12307821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.